Gold Blasts Above $5,000 as Wall Street Turns Bullish — Why Analysts Are Zeroing in on U.S. Gold Corp. (NASDAQ: USAU) as a Top American Mining Story!
Gold has surged to new historic highs above $5,000 per ounce, igniting one of the most powerful precious-metals rallies in decades. Driven by geopolitical uncertainty, currency debasement, and aggressive central-bank buying, this breakout is reshaping investor demand for hard assets. As capital rotates back into tangible stores of value, attention is rapidly shifting from gold itself to companies positioned to benefit most from higher prices—especially those operating in secure, domestic jurisdictions.
That shift is shining a spotlight on U.S. Gold Corp. (NASDAQ: USAU). With a fully permitted, shovel-ready gold-copper project in Wyoming, USAU stands out as one of the few American developers capable of near-term production leverage in a record-price gold environment.
Wall Street is taking notice: Roth Capital has raised its price target to as high as $26, Zacks has issued a Strong Buy rating, and multiple analysts point to USAU’s low projected costs, U.S.-based assets, and strategic alignment with domestic mineral policy. As gold sets new records and the market rewards execution-ready producers, USAU is emerging as a compelling U.S. mining breakout.
Trump Triggers Buying Opportunity in UnitedHealth Group
Written by Thomas Hughes. Date Posted: 1/27/2026.
Key Takeaways
- Trump's proposed rate increases sent UNH and other insurers into the buy zone.
- UNH continues to work on its turnaround, sustaining margin strength in Q4.
- The 2026 guidance is likely to be cautious, setting this stock up for outperformance as the year progresses.
The Trump administration's proposal sent ripples of fear through the insurance sector in late January, creating what some investors view as a buying opportunity in UnitedHealth Group (NYSE: UNH) and other insurers. The sell-off was driven by a proposed update to Medicare reimbursements paid to private insurers; the headline increase came in well below expectations, signaling tighter payment growth than the market had priced in.
Insurance stocks fell as a group after the announcement, with UnitedHealth among them. The company's stock price has corrected roughly 50% since mid-2025 amid CEO turnover, a major cyberattack, and heightened regulatory and investor scrutiny.
The Number One Way to Play Gold (Ad)
The #1 Way To Play Gold Right Now
We're witnessing the greatest gold rush in over 50 years...
But one gold asset has outperformed miners, typical stocks, and gold itself for the last two decades.
The reimbursement proposal does pose a risk to UNH and other insurers. Still, the 0.09% headline increase masks a different picture: the Centers for Medicare and Medicaid Services (CMS) noted that the actual reimbursement, on a per-client average, will be more than 2.5%, a figure that aligns with long-term growth expectations.
There is also ample opportunity for the administration to amend the proposal, for Congress to intervene, or for CMS — which finalizes the rates — to set different levels before the new rates take effect in 2027. Historically, CMS final rates can diverge from presidential recommendations because of the formulaic nature of Medicare and Medicaid payments.
UnitedHealth's Dividend Looks Secure as Buybacks Continue
UnitedHealth Group's stock is trading near cycle lows, and, importantly, capital returns continue to flow.
Share repurchases and dividends remain priorities for the company.
UnitedHealth Group's dividend is safe and reliable; the biggest risk is a slowdown in the pace of buybacks.
The company still expects to reduce its share count in 2026 and 2027, extending buyback-driven momentum after a 1.8% reduction in 2025.
The dividend yield tops 2.5% while the stock trades near long-term lows, and the payout ratio is a manageable and sustainable 40%, leaving cash flow to support annual increases.
UnitedHealth appears on a path toward inclusion in the Dividend Aristocrats list, a milestone likely to be achieved by the middle of the next decade.
UnitedHealth Group Delivers Margin Strength Amid Turnaround Efforts
UnitedHealth struggled in Q4 as several one‑off expenses impaired results. The company reported $113.21 billion in net revenue, up more than 12% year-over-year (YOY) but roughly 50 basis points below estimates. That top-line miss was muted by stronger-than-expected margins, which came in ahead of MarketBeat's consensus. Segment performance was mixed: UnitedHealthcare rose about 17% YOY, while Optum grew nearer 8%.
On margins, higher costs were largely offset by operational efficiency. The medical care ratio increased, while the operational ratio remained flat, leaving earnings roughly in line with MarketBeat's consensus despite the revenue shortfall. These results should be sufficient to sustain financial health and capital returns, and guidance calls for further margin improvement in the coming year.
Analysts and Institutional Activity Align With UNH's Bottom
Analyst and institutional activity now align with a 2025/2026 bottom. Analysts who pressured the stock with downward target revisions shifted stance late in 2025. The consensus rating held at Moderate Buy, and several firms reiterated or raised price targets, helping to halt the sell-off and form a bottom in the share price.
Institutions, which collectively own about 85% of the stock, bought on balance through 2025, underscoring the deep value some investors see. If analyst and institutional sentiment remain steady in 2026, that support could help set the stage for a rebound before year-end. 
UNH's roughly 10% January price plunge followed the Trump administration's announcement and occurred the evening before the Q4 report was released, pushing the stock back to a key support level and reinforcing the bottom thesis. The stock could continue to retreat and potentially retest 2025 lows, but a materially lower low is not expected. The more likely scenario is that UNH reconfirms support at or near the $300 level and rebuilds its base.
This email communication is a paid sponsorship sent on behalf of Huge Alerts, a third-party advertiser of MarketBeat. Why did I get this email?.
If you need help with your account, please don't hesitate to email MarketBeat's South Dakota based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
Copyright 2006-2026 MarketBeat Media, LLC. All rights protected.
345 N Reid Place, Sixth Floor, Sioux Falls, S.D. 57103-7078. U.S.A..


Post a Comment
Post a Comment